[Skip to Navigation]
June 1951


AMA Arch Ophthalmol. 1951;45(6):657-665. doi:10.1001/archopht.1951.01700010672007

THERE have been a number of recent favorable reports on the use of aureomycin in ophthalmology. The claim that it is a specific drug against many virus diseases naturally leads to the question whether it is equally efficacious in the treatment of trachoma, a disease which many authorities now believe belongs to the group of virus infections. Cases of trachoma make up over 50 per cent of all ophthalmic cases in the charity hospitals of this city. With such an abundance of clinical material at hand, I have taken advantage of the offer of the Lederle Laboratories Division, American Cyanamid Co., New York, to use its free supply of aureomycin for a study of the effect of this drug on a series of selected trachoma patients.

PLAN OF STUDY  We usually do not hospitalize trachoma patients no matter how serious their condition. They are treated and operated on in the

Add or change institution